Effect of oral glutamine on enterocyte turnover during methotrexate-induced mucositis in rats

Digestion

Volumn 79, Issue 1, 2009, Pages 5-13

  Sukhotnik, Igor ^a,b,c   Mogilner, Jorge G ^b   Karry, Rahel ^a   Shamian, Benhoor ^a   Lurie, Michael ^c   Kokhanovsky, Natalie ^b   Ure, Benno M ^d   Coran, Arnold G ^e  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^b Department of Pediatric Surgery ^*  (Israel)

^c BNAI ZION MEDICAL CENTER   (Israel)

^d HANNOVER MEDICAL SCHOOL   (Germany)

^e UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Enterocyte apoptosis; Enterocyte proliferation; Glutamine; Intestine; Methotrexate

Indexed keywords

DNA; GLUTAMINE; MESSENGER RNA; METHOTREXATE; PROTEIN BAX; PROTEIN BCL 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; CRYPT CELL; DRUG EFFECT; GENE EXPRESSION; ILEUM; INTESTINE CELL; INTESTINE VILLUS; JEJUNUM; MALE; MUCOSA INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCORING SYSTEM; SINGLE DRUG DOSE; SPRAGUE DAWLEY RAT; TURNOVER TIME; WEIGHT CHANGE;

ADMINISTRATION, ORAL; ANALYSIS OF VARIANCE; ANIMALS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; ENTEROCYTES; GLUTAMINE; INTESTINAL MUCOSA; MALE; METHOTREXATE; MUCOSITIS; PROTO-ONCOGENE PROTEINS C-BCL-2; RATS; RATS, SPRAGUE-DAWLEY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 58149386730     PISSN: 00122823     EISSN: None     Source Type: Journal    
DOI: 10.1159/000191209     Document Type: Article

References (23)

1. Mitchell EP, Schein PS: Gastrointestinal toxicity of chemotherapeutic agents. Semin Oncol 1982; 9: 52-64.
2. Sonis ST: Complications of cancer and their treatment: oral complications; in Holland JF, Frei E, Bast RC (eds): Cancer Medicine, ed 3. Philadelphia, Lea & Febiger, 1993, pp 2381-2388.
3. Pinkerton CR, Cameron CH, Sloan JM, Glasgow JF, Gwevava NJ: Jejunal crypt cell abnormalities associated with methotrexate treatment in children with acute lymphoblastic leukaemia. J Clin Pathol 1982; 35: 1272-1277.
4. Goldman ID, Matherly LH: The cellular pharmacology of methotrexate. Pharmacol Ther 1985; 28: 77-102.
5. Keefe DM, Brealey J, Goland GJ, Cummins AG: Chemotherapy for cancer causes apoptosis that precedes hypoplasia in crypts of the small intestine in humans. Gut 2000; 47: 632-637.
6. Cohen GM: Caspases: the executioners of apoptosis. Biochem J 1997; 326: 1-16.
7. Boise LH, Gottschalk AR, Quintans J, Thompson CB: Bcl-2 and Bcl-2-related proteins in apoptosis regulation. Curr Top Microbiol Immunol 1995; 200: 107-121.
8. Chomczynski P: A reagent for the single-step simultaneous isolation of RNA, DNA and proteins from cell and tissue samples. BioTechniques 1993; 15: 532-534.
9. Park PO, Haglund U, Bulkley GB, Falt K: The sequence of development of intestinal tissue injury after strangulation ischemia and reperfusion. Surgery 1990; 107: 574-580.
10. Van der Hulst RR, von Meyenfeldt MF, Soeters PB: Glutamine: an essential amino acid for the gut. Nutrition 1996; 12(suppl):S78-S81.
11. Wildhaber BE, Lynn KN, Yang H, Teitelbaum DH: Total parenteral nutrition-induced apoptosis in mouse intestinal epithelium: regulation by the Bcl-2 protein family. Pediatr Surg Int 2002; 18: 570-579.
12. Chapman MA, Grahn MF, Giamundo P, O'Connell PR, Onwu D, Hutton M, Maudsley J, Norton B, Rogers J, Williams NS: New technique to measure mucosal metabolism and its use to map substrate utilization in the healthy human large bowel. Br J Surg 1993; 80: 445-449.
13. Windmuelle HG, Spaeth AE: Uptake and metabolism of plasma glutamine by the small intestine. J Biol Chem 1974; 249: 5070-5079.
14. Sukhotnik I, Khateeb K, Mogilner JG, Helou H, Lurie M, Coran AG, Shiloni E: Dietary glutamine supplementation prevents mucosal injury and modulates intestinal epithelial restitution following ischemia-reperfusion injury in the rat. Dig Dis Sci 2007; 52: 1497-1504.
15. Sukhotnik I, Agam M, Shamir R, Shehadeh N, Lurie M, Coran AG, Shiloni E, Mogilner J: Oral glutamine prevents gut mucosal injury and improves mucosal recovery following lipopolysaccharide endotoxemia in a rat. J Surg Res 2007; 143: 379-384.
16. Altman GG: Changes in the mucosa of the small intestine following methotrexate administration or abdominal X-radiation. Am J Anat 1974; 140: 263-279.
17. Jeynes BJ, Altmann GG: Light and scanning electron microscopic observations of the effects of sublethal doses of methotrexate on the rat small intestine. Gut 1978; 47: 632-637.
18. Ortega M, Gomez-de-Segura IA, Vazquez I, Lopez JM, de Guevara CL, De-Miguel E: Effects of growth hormones plus a hyperproteic diet on methotrexate-induced injury in rat intestines. Acta Oncol 2001; 40: 615-621.
19. Xian CJ, Cool JC, Howarth GS, Read LC: Effects of TGF-alpha gene knockout on epithelial cell kinetics and repair of methotrexateinduced damage in mouse small intestine. J Cell Physiol 2002; 191: 105-115.
20. Rombeau JL: A review of the effects of glutamine-enriched diets on experimentally induced enterocolitis. JPEN J Parenter Enteral Nutr 1990; 4(suppl):100S-105S.
21. Shou J, Lieberman MD, Hofmann K, Leon P, Davies H, Daly JM: Dietary manipulation of methotrexate-induced enterocolitis. JPEN J Parenter Enteral Nutr 1991; 15: 307-312.
22. Sukhotnik I, Shteinberg D, Ben Lulu S, Bashenko Y, Mogilner JG, Lurie M, Ure B, Coran AG: Effect of Transforming growth factoralpha on enterocyte apoptosis is correlated with EGF receptor expression along the villus-crypt axis during methotrexate-induced intestinal mucositis in a rat. Apoptosis, in press.
23. Ono K, Mawatari K, Harada N, Takahashi A, Sakai T, Ogoshi S, Nakaya Y: The nucleoside and nucleotide mixture (OG-VI) rescues intestinal-like epithelial cells from the cytotoxicity of chemotherapeutic agents. J Med Invest 2007; 54: 235-242.